Institutional Ownership Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX). We have compiled data on the 49 institutions that hold shares in the stock, with a total of 3.54 Million shares, which have been reported (via 13F filing form) to have a value of $6.02 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
955,900
shares
|
$1.62 Million
0.0% of portfolio
|
Q3 2024
Added 18.8%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
435,213
shares
|
$735,509
0.03% of portfolio
|
Q3 2024
Added 8.47%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
373,757
shares
|
$631,649
0.0% of portfolio
|
Q3 2024
Reduced 53.92%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
333,171
shares
|
$563,058
0.0% of portfolio
|
Q2 2024
Reduced 89.94%
|
|
|
Stratos Wealth Partners, Ltd.
|
Oct 17, 2024 Q3 2024 |
270,000
shares
|
$456,300
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
183,790
shares
|
$310,605
0.0% of portfolio
|
Q1 2024
Reduced 11.97%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
91,658
shares
|
$154,902
0.0% of portfolio
|
Q3 2024
Added 396.31%
|
|
|
Orin Green Financial, LLC
|
Oct 16, 2024 Q3 2024 |
72,000
shares
|
$121,680
0.03% of portfolio
|
Q1 2024
Reduced 10.0%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
70,817
shares
|
$119,680
0.0% of portfolio
|
Q3 2024
Reduced 55.25%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
55,418
shares
|
$93,656
0.0% of portfolio
|
Q3 2024
Reduced 59.77%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
52,291
shares
|
$88,371
0.0% of portfolio
|
Q3 2024
Reduced 87.64%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
50,241
shares
|
$84,907
0.0% of portfolio
|
Q3 2024
Reduced 89.12%
|
|
|
Commonwealth Equity Services, LLC
|
Oct 18, 2024 Q3 2024 |
50,000
shares
|
$84,500
0.0% of portfolio
|
Q3 2024
Reduced 0.2%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
47,073
shares
|
$79,553
0.01% of portfolio
|
Q3 2024
Reduced 30.94%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
45,952
shares
|
$77,658
0.0% of portfolio
|
Q3 2024
Reduced 84.17%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
44,994
shares
|
$76,039
0.0% of portfolio
|
Q3 2024
Reduced 59.52%
|
|
|
Virtu Financial LLC
New York, NY |
Nov 20, 2024 Q3 2024 |
43,388
shares
|
$73,325
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
43,058
shares
|
$72,768
0.0% of portfolio
|
Q3 2024
Reduced 50.59%
|
|
|
Hsbc Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
40,023
shares
|
$67,638
0.0% of portfolio
|
Q3 2024
Reduced 15.96%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
36,438
shares
|
$61,580
0.0% of portfolio
|
Q3 2024
Reduced 69.89%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
35,058
shares
|
$59,248
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
34,323
shares
|
$58,005
0.0% of portfolio
|
Q3 2024
Reduced 3.12%
|
|
|
Capital Performance Advisors LLP
|
Nov 01, 2024 Q3 2024 |
25,976
shares
|
$43,899
0.01% of portfolio
|
Q3 2024
Reduced 3.05%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
23,621
shares
|
$39,919
0.0% of portfolio
|
Q3 2024
Reduced 26.26%
|
|
|
Aptus Capital Advisors, LLC
|
Nov 05, 2024 Q3 2024 |
22,337
shares
|
$37,749
0.0% of portfolio
|
Q3 2024
Added 6.75%
|